MPM Oncology Impact Management GP LLC, 10% Owner at Cullinan Oncology, Inc. (CGEM), sold 5,020 shares at $29.05 ($146K) on 2021-08-11, disclosed to the SEC on 2021-08-12.
Scheduled sale ($146k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.05 | 2,510 | $73K | 50.0% |
| 2 | $29.05 | 2,510 | $73K | 50.0% |
| Total | $29.05 avg | 5,020 | $146K | 100% |
| Filing → |
| HARP | SELL | 2021-05-17 | $520K | — | Filing → |
| HARP | SELL | 2021-05-04 | $14.7M | — | Filing → |
| HARP | SELL | 2021-04-22 | $330K | — | Filing → |